NCT05817370 Implementation of Anal Cancer Screening and Treatment in Nigeria
| NCT ID | NCT05817370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, Baltimore |
| Condition | Education, Medical |
| Study Type | INTERVENTIONAL |
| Enrollment | 1 participants |
| Start Date | 2023-05-02 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1 participants in total. It began in 2023-05-02 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is a feasibility pilot trial testing 2 types of training protocols on a single physician. The first training protocol is the current standard and was developed in high-income settings. The second training protocol will be developed so tailored to the Nigerian setting. Investigators will test if the physician performs differently in their ability to conduct anal cancer screening and treatment between the 2 training protocols.
Eligibility Criteria
Inclusion Criteria: 1. Possess a medical degree in medical sciences (MBBS or equivalent) 2. At least 2-5 years of experience working with clinical HIV/AIDS community 3. Must be registered with the medical and dental council of Nigeria 4. Possess a current medical practicing license 5. Willing to work with the Sexual Gender Minority Community Exclusion Criteria:
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05817370 clinical trial?
This trial is open to participants of all sexes, studying Education, Medical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05817370 currently recruiting?
Yes, NCT05817370 is actively recruiting participants. Contact the research team at rnowak@ihv.umaryland.edu for enrollment information.
Where is the NCT05817370 trial being conducted?
This trial is being conducted at Abuja, Nigeria.
Who is sponsoring the NCT05817370 clinical trial?
NCT05817370 is sponsored by University of Maryland, Baltimore. The trial plans to enroll 1 participants.